Drugs / Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell）
Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell）
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT06209398 | May 2018 → Dec 2024 | hand, foot and mouth disease | Jiangsu Province Centers for Disease Control and Prevention | Unknown | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05397587 Comparator | Jul 2022 → Jul 2025 | hand, foot and mouth disease | Sinovac Biotech Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell） | “Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell）” NCT05397587 ↗ |
| Modality | Vaccine | “Inactivated Vaccine” NCT05397587 ↗ |
| Route | Intramuscular | “Intramuscular injection into the deltoid muscle of the upper arm.” NCT06209398 ↗ |